HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Clarins S.A.

This article was originally published in The Rose Sheet

Executive Summary

Clarins S.A.: Cites the launch of new products in the first quarter of 1995 -- including Bio Ecolia cleansers, Contouring Body Lift and Rouge Eclat lipsticks -- in explaining the company's 15.7% sales increase (at constant exchange rates). Sales rose 11% based on average exchange rates. Clarins also reported that it is negotiating the "possibility of developing" a men's scent bearing the name of British clothing designer, Paul Smith. The scent would debut "within the next year" if negotiations are successful, the company says. The new fragrance would be marketed by Clarins' Thierry Mugler Parfums subsidiary. In addition, Clarins said it acquired a factory in Orangeburg, NY from Parfums Yves Saint Laurent for $6.5 mil in January. The factory initially will be used as a warehouse but could be converted to a production facility, Clarins said...
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS001563

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel